National Medical Insurance Administration Zhang Ke: Currently, more than one hundred types of drugs have applied to be included in the commercial insurance innovative drug list.

Zhang Ke, Director of the National Healthcare Security Administration, revealed at the "High-Quality Completion of the 14th Five-Year Plan" series of themed press conference held on July 24th, that currently, through single catalog declaration and dual catalog declaration, a total of more than 100 varieties of drugs have applied to be included in the innovative drug catalog. The National Healthcare Security Administration will follow the prescribed procedures to do the subsequent work.